Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients

Atherosclerosis Supplements

Volumn 10, Issue 5, 2009, Pages 95-101

  Heigl, Franz ^a   Hettich, Reinhard ^a   Suckfuell, Markus ^b   Luebbers, Christian W ^c   Osterkorn, D ^d   Osterkorn, K ^d   Canis, Martin ^b  

^a Dres Heigl   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Klinikum Dachau   (Germany)

^d Medizinisches Wirtschaftsinstitut   (Germany)

Author keywords

Fibrinogen LDL apheresis; Observational study; Remission rate; Sudden sensorineural hearing loss

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CALCIUM; CREATININE; FIBRINOGEN; GLUCOSE; HEMOGLOBIN; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; SODIUM; TRIACYLGLYCEROL; UREA; URIC ACID;

ACOUSTIC REFLEX; ACUTE DISEASE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; APHERESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUDITORY THRESHOLD; BILIRUBIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE DURATION; ERYTHROCYTE; FEMALE; FIBRINOGEN BLOOD LEVEL; GERMANY; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PARTIAL THROMBOPLASTIN TIME; PERCEPTION DEAFNESS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PURE TONE AUDIOMETRY; REMISSION; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SUDDEN DEAFNESS; THROMBOCYTE; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; TYMPANOMETRY; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ACOUSTIC IMPEDANCE TESTS; ACOUSTIC STIMULATION; ADULT; AGED; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; BIOLOGICAL MARKERS; BLOOD COMPONENT REMOVAL; COCHLEA; FEMALE; FIBRINOGEN; GERMANY; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HEMORHEOLOGY; HUMANS; LIPOPROTEINS, LDL; MALE; MICROCIRCULATION; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 72749093484     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5688(09)71820-3     Document Type: Article

References (38)

1. Olzowy B., Osterkorn D., and Suckfuell M. The incidence of sudden hearing loss is greater than previously assumed. MMW. Fortschr. Med. 147 (2005) 37-38
2. Miller J.M., Ren T.Y., and Nuttall A.L. Studies of inner ear blood flow in animals and human beings. Otolaryngol. Head Neck Surg. 112 (1995) 101-113
3. Sidman J.D., Prazma J., Pulver S.H., and Pillsbury III H.C. Cochlea and heart as end-organs in small vessel disease. Ann. Otol. Rhinol. Laryngol. 97 (1988) 9-13
4. Feron O., Dessy C., Desager J.P., and Balligand J.L. Hydroxy-methylglutarylcoenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103 (2001) 113-118
5. Nguyen T.V., and Brownell W.E. Contribution of membrane cholesterol to outer hair cell lateral wall stiffness. Otolaryngol. Head Neck Surg. 119 (1998) 14-20
6. Suckfuell M., Seidel D., Thiery J., et al. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]. Z. Kardiol 92 (2003) III59-III63
7. Suzuki K., Kaneko M., and Murai K. Influence of serum lipids on auditory function. Laryngoscope 110 (2000) 1736-1738
8. Suckfuell M. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 360 (2002) 1811-1817
9. Axelsson A., and Lindgren F. Is there a relationship between hyper- cholesterolaemia and noise-induced hearing loss?. Acta Otolaryngol. 100 (1985) 379-386
10. Preyer S., Baisch A., Bless D., and Gummer A.W. Distortion product oto- acoustic emissions in human hypercholesterolemia. Hear. Res. 152 (2001) 139-151
11. Rosen S., Bergman M., Plester D., EL Mofty A., and Satti M.H. Presbycusis study of a relatively noise-free population in the Sudan. Trans. Am. Otol. Soc. 50 (1962) 135-152
12. Morizono T., and Paparella M.M. Hypercholesterolemia and auditory dys- function. Experimental studies. Ann. Otol. Rhinol. Laryngol. 87 (1978) 804-814
13. Syka J., Ouda L., Nachtigal P., Solichova D., and Semecky V. Atorvastatin slows down the deterioration of inner ear function with age in mice. Neurosci. Lett. 411 (2007) 112-116
14. Cunningham D.R., and Goetzinger C.P. Extra-high frequency hearing loss and hyperlipidemia. Audiology 13 (1974) 470-484
15. Morizono T., Sikora M.A., Ward W.D., Paparella M.M., and Jorgensen J. Hyperlipidemia and noise in the chinchilla. Acta Otolaryngol 99 (1985) 516-524
16. Saito T., Sato K., and Saito H. An experimental study of auditory dys- function associated with hyperlipoproteinemia. Arch. Otorhinolaryngol. 243 (1986) 242-245
17. Gratton M.A., and Wright C.G. Alterations of inner ear morphology in experimental hypercholesterolemia. Hear. Res. 61 (1992) 97-105
18. Fessenden J.D., and Schacht J. The nitric oxide/cyclic GMP pathway: a potential major regulator of cochlear physiology. Hear. Res. 118 (1998) 168-176
19. Ciuffetti G., Scardazza A., Serafini G., Lombardini R., Mannarino E., and Simoncelli C. Whole-blood filterability in sudden deafness. Laryngoscope 101 (1991) 65-67
20. Ohinata Y., Makimoto K., Kawakami M., Haginomori S., Araki M., and Takahashi H. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol. 114 (1994) 601-607
21. Ernst E., and Resch K.L. Fibrinogen as a cardiovascular risk factor: a meta- analysis and review of the literature. Ann. Intern. Med. 118 (1993) 956-963
22. Liberman M.C., Gao J., He D.Z., Wu X., Jia S., and Zuo J. Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier. Nature 419 (2002) 300-304
23. Zheng J., Shen W., He D.Z., Long K.B., Madison L.D., and Dallos P. Prestin is the motor protein of cochlear outer hair cells. Nature 405 (2000) 149-155
24. Rajagopalan L., Greeson J.N., Xia A., et al. Tuning of the outer hair cell motor by membrane cholesterol. J. Biol. Chem. 282 (2007) 36659-36670
25. Sturm A.K., Rajagopalan L., Yoo D., Brownell W.E., and Pereira F.A. Functional expression and microdomain localization of prestin in cultured cells. Otolaryngol. Head Neck Surg. 136 (2007) 434-439
26. Ohvo-Rekila H., Ramstedt B., Leppimaki P., and Slotte J.P. Cholesterol interactions with phospholipids in membranes. Prog. Lipid Res. 41 (2002) 66-97
27. Starke-Peterkovic T., Turner N., Vitha M.F., Waller M.P., Hibbs D.E., and Clarke R.J. Cholesterol effect on the dipole potential of lipid membranes. Biophys. J. 90 (2006) 4060-4070
28. Wei B.P., Mubiru S., and O'Leary S. Steroids for idiopathic sudden sensori- neural hearing loss. Cochrane. Database. Syst. Rev. (2006) CD003998
29. Mattox D.E., and Simmons F.B. Natural history of sudden sensorineural hearing loss. Ann. Otol. Rhinol. Laryngol. 86 (1977) 463-480
30. Wilson W.R., Byl F.M., and Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch. Otolaryngol. 106 (1980) 772-776
31. Probst R., Tschopp K., Ludin E., Kellerhals B., Podvinec M., and Pfaltz C.R. A randomized, double-blind, placebo-controlled study of dextran/ pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol. 112 (1992) 435-443
32. Alexiou C., Arnold W., Fauser C., et al. Sudden sensorineural hearing loss: does application of glucocorticoids make sense?. Arch. Otolaryngol. Head Neck Surg. 127 (2001) 253-258
33. Pfefferkorn T.K., Knuppel H.P., Jaeger B.R., Thiery J., and Hamann G.F. Increased cerebral CO(2) reactivity after heparin-mediated extra- corporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia. Stroke 30 (1999) 1802-1806
34. Mellwig K.P., van Buuren F., Schmidt H.K., Wielepp P., Burchert W., and Horstkotte D. Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment. Ther. Apher. Dial. 10 (2006) 510-517
35. Kojima Y., Ito S., and Furuya N. Hearing improvement after therapy for hyperlipidemia in patients with chronic-phase sudden deafness. Ann. Otol. Rhinol. Laryngol. 110 (2001) 105-108
36. Seidel D. H.E.L.P. apheresis therapy in the treatment of severe hyper-cholesterolemia: 10 years of clinical experience. Artif. Organs 20 (1996) 303-310
37. Shiraishi T., Kubo T., Okumura S., et al. Hearing recovery in sudden deafness patients using a modified defibrinogenation therapy. Acta Otolaryngol Suppl 501 (1993) 46-50
38. Canis M., Heigl F., Hettich R., Osterkorn D., Osterkorn K., and Suckfuell M. [Fibrinogen/LDL apheresis for treatment of sudden hearing loss: an observational study on 152 patients]. HNO 56 (2008) 961-966